Abstract
Direct contact and airborne spread are main mechanisms of transmission for SARS-CoV-2, and virus can stay viable for at least 3 hours in aerosols. Initus-V system uses a Far-ultraviolet C (UVC) system, UVC resistant textile and googles to provide virus, bacteria and spore free environments in hospitals, crowded public places and travel environments. Initus-V system may help in prevention of epidemic diseases such as Coronavirus disease-19 (Covid-19), influenza, treatment of airborne viral diseases and spread of hospital-borne resistant infections.
Competing Interest Statement
Initus-V system was developed by InnowayRG Inc and Vestel Home appliances Inc. A patent application has been made to TURKPATENT in the partnership of these two companies. (TR 2020/07546) Ayhan Olcay, Serdar Baki Albayrak, Onur Yolay are founders of InnowayRG Inc. Mehmet Cengiz Akbulbul and Mehmet Cetin Bayer are inventors Hande İkitimur and Mehmet Faruk Akturk report no conflicts of interest.
Funding Statement
Initus-V system was developed by InnowayRG Inc and Vestel Home appliances Inc. A patent application has been made to TURKPATENT in the partnership of these two companies. (TR 2020/07546) Ayhan Olcay, Serdar Baki Albayrak, Onur Yolay are founders of InnowayRG Inc. Mehmet Cengiz Akbulbul and Mehmet Cetin Bayer are inventors Hande İkitimur and Mehmet Faruk Akturk report no conflicts of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee of Ataturk University, Erzurum, Turkey has approved study
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All referred data is available
